The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcome and prognostic factors in stage III favorable histology Wilms tumor (FHWT): A report from the Children’s Oncology Group (COG) study AREN0532.
 
Conrad Vincent Fernandez
Stock and Other Ownership Interests - DiagnoCure (I)
 
Elizabeth Anne Mullen
No Relationships to Disclose
 
Peter F. Ehrlich
No Relationships to Disclose
 
John A. Kalapurakal
Honoraria - Elekta
 
Geetika Khanna
Research Funding - Biomedical Systems
 
Yueh-Yun Chi
No Relationships to Disclose
 
Elizabeth Perlman
No Relationships to Disclose
 
Arnold Paulino
Employment - MD Anderson Cancer Center
Patents, Royalties, Other Intellectual Property - Elsevier Inc
 
Thomas Edward Hamilton
No Relationships to Disclose
 
Kenneth William Gow
Employment - Amgen (I)
Stock and Other Ownership Interests - Amgen (I)
 
Fernando Anthony Ferrer
No Relationships to Disclose
 
Zelig Tochner
No Relationships to Disclose
 
Qi An
No Relationships to Disclose
 
Fredric A. Hoffer
No Relationships to Disclose
 
Janice Withycombe
No Relationships to Disclose
 
Robert C. Shamberger
No Relationships to Disclose
 
James I. Geller
Consulting or Advisory Role - Bayer
Research Funding - Pfizer
 
James Robert Anderson
Consulting or Advisory Role - Amgen; Merck; SFJ Pharmaceuticals Group
 
Paul Edward Grundy
No Relationships to Disclose
 
Jeffrey S. Dome
Patents, Royalties, Other Intellectual Property - Rockland Immunochemicals; Rockland Immunochemicals (Inst)